Original Article

Cutaneous Community-acquired Methicillin-resistant Staphylococcus aureus Infection in Participants of Athletic Activities

Authors: Philip R. Cohen, MD

Abstract

Objectives: Cutaneous community-acquired methicillin-resistant Staphylococcus aureus(CAMRSA) has been identified in otherwise healthy individuals either with or without methicillin-resistant S. aureus (MRSA)-associated risk factors who participate in athletic activities. The purpose of this study was to describe the clinical features of CAMRSA skin infection that occurred in university student athletes, evaluate the potential mechanisms for the transmission of MRSA infection of the skin in participants of athletic activities, and review the measures for preventing the spread of cutaneous CAMRSA infection in athletes.


Methods: A retrospective chart review of the student athletes from the University of Houston whose skin lesions were evaluated at the Health Center and grew MRSA was performed. The clinical characteristics and the postulated mechanisms of cutaneous MRSA infection in the athletes were compared with those previously published in reports of CAMRSA skin infection outbreaks in other sports participants.


Results: Cutaneous CAMRSA infection occurred in seven student athletes (four women and three men) who were either weight lifters (three students) or members of a varsity sports team: volleyball (two women), basketball (one woman), and football (one man). The MRSA skin infection presented as solitary or multiple, tender, erythematous, fluctuant abscesses with surrounding cellulitis. The lesions were most frequently located in the axillary region (three weight lifters), on the buttocks (two women), or on the thighs (two women). The drainage from all of the skin lesions grew MRSA, which was susceptible to clindamycin, gentamicin, rifampin, trimethoprim/sulfamethoxazole, and vancomycin; five of the isolates were also susceptible to ciprofloxacin and levofloxacin. All of the bacterial strains were resistant to erythromycin, oxacillin, and penicillin. The cutaneous MRSA infections persisted or worsened in the six athletes who were empirically treated for methicillin-sensitive S. aureus at their initial visit. Complete resolution of the skin infection occurred after the abscesses had been drained and the athlete had been treated with systemic antimicrobial therapy for which the bacterial strain was susceptible.


Conclusions: Cutaneous CAMRSA infection typically presents as an abscess, with or without surrounding cellulitis, in otherwise healthy participants of athletic activities who have or do not have MRSA-associated risk factors. Athletes who have MRSA skin infections include weight lifters and team members from competitive sports such as basketball, fencing, football, rugby, volleyball, and wrestling. Bacterial culture of suspected infectious skin lesions should be performed to establish the diagnosis of cutaneous MRSA infection and to determine the antibiotic susceptibility of the bacterial isolate. Treatment of cutaneous MRSA infection involves drainage of the abscess (either spontaneously or after incision) and appropriate systemic antimicrobial therapy. Direct skin-to-skin physical contact with infectious lesions or drainage, skin damage that facilitates the entry of bacteria, and sharing of infected equipment, clothing, or personal items may result in the acquisition and transmission of MRSA infection in participants of athletic activities. Earlier detection and topical treatment of the athlete's skin wounds by their coaches, avoidance of contact with other participants' cutaneous lesions and their drainage, and good personal hygiene are measures that can potentially prevent the spread of cutaneous MRSA infection in participants of athletic activities.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Said-Salim B, Mathema B, Kreiswirth BN. Community-acquired methicillin-resistant Staphylococcus aureus: an emerging pathogen. Infect Control Hosp Epidemiol 2003;24:451–455.
 
2. Vandenesch F, Naimi T, Enright MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis2003;9:978–984.
 
3. Cohen PR, Grossman ME. Management of cutaneous lesions associated with an emerging epidemic: community-acquired methicillin-resistant. Staphylococcus aureus skin infections [commentary]. J Am Acad Dermatol 2004;51:132–135.
 
4. Eady EA, Cove JH. Staphylococcal resistance revisited: community-acquired methicillin resistantStaphylococcus aureus: an emerging problem for the management of skin and soft tissue infections.Curr Opin Infect Dis 2003;16:103–124.
 
5. Lee MC, Rios AM, Aten MF, et al. Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureusPediatr Infect Dis J 2004;23:123–127.
 
6. Cohen PR, Kurzrock R. Community-acquired methicillin-resistant Staphylococcus aureus skin infection: an emerging clinical problem. J Am Acad Dermatol 2004;50:277–280.
 
7. Lindenmayer JM, Schoenfeld S, O'Grady R, et al. Methicillin-resistant Staphylococcus aureus in a high school wrestling team and the surrounding community. Arch Intern Med 1998;158:895–899.
 
8. Stacey AR, Endersby KE, Chan PC, et al. An outbreak of methicillin resistant Staphylococcus aureus infection in a rugby football team. Br J Sport Med 1998;32:153–154.
 
9. Centers for Disease Control and Prevention. Outbreaks of community-associated methicillin-resistantStaphylococcus aureus skin infections: Los Angeles County, California, 2002–2003. MMWR Morb Mortal Wkly Rep 2003;52:88.
 
10. Centers for Disease Control and Prevention. Methicillin-resistant Staphylococcus aureus infections among competitive sports participants: Colorado, Indiana, Pennsylvania, and Los Angeles County, 2000–2003. MMWR Morb Mortal Wkly Rep 2003;52:793–795.
 
11. Cohen PR. Community-acquired methicillin-resistant Staphylococcus aureus skin infection presenting as an axillary abscess with cellulitis in a college athlete. SKINmed 2005;4:115-118.
 
12. Gosbell IB, Mercer JL, Neville SA, et al. Non-multiresistant and multiresistant methicillin-resistantStaphylococcus aureus in community-acquired infections. Med J Aust 2001;174:627–630.
 
13. Dietrich DW, Auld DB, Mermel LA. Community-acquired methicillin-resistant Staphylococcus aureus in Southern New England children. Pediatrics 2004;113:e347–e352. (http://www.pediatrics.org/cgi/content/full/113/4/e347).
 
14. Fang YH, Hsueh PR, Hu JJ, et al. Community-acquired methicillin-resistant Staphylococcus aureusin children in northern Taiwan. J Microbiol Immunol Infect 2004;37:29–34.
 
15. Palavecino E. Community-acquired methicillin-resistant Staphylococcus aureus infections. Clin Lab Med 2004;24:403–418.
 
16. Naimi TS, LeDell KH, Como-Sabetti K, et al. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 2003;290:2976–2984.
 
17. Diep BA, Sensabaugh GF, Somboona NS, et al. Widespread skin and soft-tissue infections due to two methicillin-resistant Staphylococcus aureus strains harboring the genes for Panton-Valentine leucocidin. J Clin Microbiol 2004;42:2080–2084.
 
18. Baggett HC, Hennessy TW, Rudolph K, et al. Community-onset methicillin-resistantStaphylococcus aureus associated with antibiotic use and the cytotoxin Panton-Valentine leukocidin during a furunculosis outbreak in rural Alaska. J Infect Dis 2004;189:1565–1573.
 
19. Cohen PR. What caused this abscess and cellulitis? Diagnosis: Community-acquired methicillin-resistant Staphylococcus aureus (CAMRSA) skin infection. Skin & Aging 2004;12:56-58.
 
20. Boyce JM. MRSA patients: proven methods to treat colonization and infections. J Hosp Infect2001;48(Suppl A):S9–S14.
 
21. Semret M, Miller MA. Topical mupirocin for eradication of MRSA colonization with mupirocin-resistant strains. Infect Control Hosp Epidemiol 2001;22:578–580.
 
22. Kampf G, Kramer A. Eradication of methicillin-resistant Staphylococcus aureus with antiseptic soap and nasal mupirocin among colonized patients: an open uncontrolled clinical trial. Ann Clin Microbiol Antimicrob 2004;3:9 (http://www.ann-clinmicrob.com/content/3/1/9).